Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
FTXHvsVHTETF Comparison
First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Vanguard Health Care ETF (VHT) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.09% for VHT. FTXH is up 2.6% year-to-date (YTD) with +$7M in YTD flows. VHT performs worse with -3.65% YTD performance, and -$151M in YTD flows. Run a side-by-side ETF comparison of FTXH and VHT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
FTXH vs VHT performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FTXH VHT | -2.89%-3.64% | +3.86%-3.14% | +2.60%-3.65% | +22.74%+7.10% | +39.72%+25.93% | +37.82%+31.22% |
| Flows | FTXH VHT | +$4M-$68M | +$9M-$245M | +$7M-$151M | +$10M-$693M | -$13M-$2.52B | +$7M-$233M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FTXH VHT | +15.86%+13.62% | +20.64%+17.40% | +15.91%+13.66% | +15.69%+14.99% |
| Max drawdown | FTXH VHT | -5.21%-6.72% | -16.42%-11.85% | -19.32%-16.88% | -19.32%-17.77% |
| Max drawdown duration | FTXH VHT | 11d64d | 165d190d | 393d435d | 393d767d |
FTXH | VHT | |
Last sale 3/13/2026 at 1:30 PM | $33.63 | $276.67 |
| Previous close 03/12/2026 | $33.78 | $277.21 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
FTXH | VHT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
FTXH | VHT | |
|---|---|---|
| Last price | $33.63 | $276.67 |
| 1D performance | -0.45% | -0.19% |
| AuM | $28.72 M | $16.55 B |
| E/R | 0.6% | 0.09% |
FTXH | VHT | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | First Trust | Vanguard |
| Benchmark | NASDAQ US Smart Pharmaceuticals Index | MSCI US IMI Health Care 25/50 Index |
| N° of holdings | 49 | 352 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 20, 2016 | January 26, 2004 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the FTXH and VHT ETFs performed in 2026?
As of March 12, 2026, FTXH is up 2.6% year-to-date (YTD), while VHT has lost -3.65%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: FTXH or VHT?
Year-to-date, the FTXH ETF saw +$7M in flows, compared to -$151M for VHT.
Which ETF is more volatile: FTXH or VHT?
Over the past year, FTXH had a volatility of 20.64%, while VHT experienced 17.4%.
Which ETF is bigger: FTXH or VHT?
As of March 12, 2026, FTXH holds $28.72 M in assets under management (AUM), while VHT manages $16.55 B.
What sectors do the FTXH and VHT ETFs invest in?
FTXH leans toward sectors like Health Care. Meanwhile, VHT focuses on Health Care.
What are the top holdings of the FTXH ETF and VHT ETF?
FTXH top holdings include MERCK & CO INC, JOHNSON&JOHNSON and BRISTOL-MYERS SQUIBB. VHT holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.
Which ETF is more diversified: FTXH or VHT?
FTXH holds 50 securities with 71.63% of its assets in the top 15. VHT has 408 securities and a top 15 weight of 60.02%.
My Contrarian Equity ETF Picks For 2026
Healthcare Stocks Drop on Medicare Payment Rate Surprise
Health Care Sector Down After a Cyberattack on UnitedHealth
2024 Stock Market Predictions from Vanguard, BlackRock, & State Street: ETFs to Watch
Tony's ETF Buyer's Guide: Sector ETFs (Vanguard versus State Street SPDR)
Defensive investing: Utility and healthcare sector ETFs
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
